The overall goal of this proposal is to investigate the role of inducible forms of nitric oxide in the expression of salt-mediated hypertension in the Dahl/Rapp genetic rat model. The author has accumulated a significant amount of experimental evidences showing that vascular smooth muscle isoform of inducible NOS (NOS2b) of S rat contains a single point of mutation that results in an amino acid substitution at position 714. Such a mutation induced a decrease in the affinity of the enzyme for L-arginine as compared to wild type NOS2b which is responsible for determining salt-sensitive hypertension. The proposal has two major objectives. The first objective is to determine to role of NOS2b gene defect and determining the abnormal function of the enzyme in the production of hypertension in the rat. These goals are accomplished by expressing the wild type NOS2b and the S714P mutant in COS-7 cells to measure Km and determining whether the serine at this position is phosphorylated; examining eight different inbred strains of rat for the S714P mutation using restriction fragment length polymorphism (RFLP) analysis; determining whether the NOS2b RFLP cosegregates with hypertension in an F2 cross between S and R rats; and developing congenic rat strains that posses the NOS2b, S714P mutation and derived from S rats crossed with WKY rats in order to understand the contribution of this mutation to the phenotype of salt-sensitive hypertension and hypertensive nephrosclerosis in vivo. The second long term objective is to determine the manner in which the effect of dietary salt affects steady-state mRNA and protein levels of NOS2b as well as NOS1 and NOS3. These goals also include experiments to examine the mechanism of transport of L-arginine into the smooth muscle cells and determine if this transport is altered in S rats. The proposal also contains studies to determine the mechanism of renal damage in Dahl/Rapp rats. The author has produced evidences indicating that extracellular matrix overproduction in small arterioles and glomerular mesangium is associated with the progressive renal disease in these rats. In this line, the studies aim at determining the role of a defective NO production along with an abnormal responsive angiotensin II on the formation of fibrogenic growth factor.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK046199-04A2
Application #
2016634
Study Section
Special Emphasis Panel (ZRG4-CVB (03))
Project Start
1992-09-30
Project End
2001-03-31
Budget Start
1997-05-16
Budget End
1998-03-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Ying, Wei-Zhong; Aaron, Kristal J; Sanders, Paul W (2014) Sodium and potassium regulate endothelial phospholipase C-? and Bmx. Am J Physiol Renal Physiol 307:F58-63
Ying, Wei-Zhong; Aaron, Kristal J; Sanders, Paul W (2013) Transforming growth factor-? regulates endothelial function during high salt intake in rats. Hypertension 62:951-6
Kanbay, Mehmet; Bayram, Yeter; Solak, Yalcin et al. (2013) Dietary potassium: a key mediator of the cardiovascular response to dietary sodium chloride. J Am Soc Hypertens 7:395-400
Allen, Christopher E; Sanders, Paul W (2013) Hypertensive nephrosclerosis: not enough of a good thing? Am J Physiol Renal Physiol 304:F674-5
Taler, Sandra J; Agarwal, Rajiv; Bakris, George L et al. (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis 62:201-13
Ahmed, Ali; Rich, Michael W; Zile, Michael et al. (2013) Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. Am J Med 126:150-61
DuPont, Jennifer J; Greaney, Jody L; Wenner, Megan M et al. (2013) High dietary sodium intake impairs endothelium-dependent dilation in healthy salt-resistant humans. J Hypertens 31:530-6
Mrug, Michal; Sanders, Paul W (2013) Beware the low HDAC11: males at risk for ischemic kidney injury. Am J Physiol Renal Physiol 305:F973-4
Bowling, C Barrett; Sanders, Paul W; Allman, Richard M et al. (2013) Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial. Int J Cardiol 167:151-6
Aaron, Kristal J; Sanders, Paul W (2013) Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clin Proc 88:987-95

Showing the most recent 10 out of 65 publications